OR WAIT null SECS
Market-data firm estimates 2020 global drug sales at $987 billion
The annual report from Evaluate Pharma, World Preview 2015, Outlook to 2020, compiles a variety of data on research, drug pipelines, and current and projected sales. By its count, the No. 1 biopharma company in the world both in 2014 and 2020, will be Novartis, with projected sales of $53.3 billion (the company tracks only drug sales, and not other businesses that biopharma firms might be engaged in). Pfizer, the longtime No. 1 firm until recently, is projected to remain No. 2, even though 2020 sales will be essentially flat from 2014’s $4.6 billion. In fact, the top 20 firms collectively will show CAGR of 3%, while the projection for global sales will rise with a CAGR of 5%, to $987 billion. Companies not among the top 20 will grow at a CAGR of 8%.
Some other tidbits from the Evaluate Pharma report:
The full report is available for download at www.evaluatepharma.com.